Krebs Biochemicals and Industries Ltd

₹ 64.25

icon 1.29 | 1.99
Market Cap ₹( Cr.)
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
Proj. Revenue ( Cr.)

Stock View

Last Updated On.

The average score for Krebs Biochemicals and Industries Ltd stands at 4 against 1, three months back.

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry. It is also engaged in chemical synthesis, fermentation and enzymatic technologies. It manufactures various products, such as Androstenedione for use as steroid intermediate, and Lovastatin and Simvastatin for anti-cholesterol. It also undertakes contract manufacturing for pharmaceutical and multinational companies and developing products for sale in global markets. It has also products in the pilot or research and development stages, which include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. It has two manufacturing facilities, one is located at Regadichelaka, Nellore District, and another one located at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data

50 DMA(₹)
100 DMA(₹)
200 DMA(₹)
52 Weeks Range
51.10     126.00

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required